Very long-term survival of an older glioblastoma patient after treatment with cilengitide: a case report
Sign Up to like & getrecommendations! Published in 2023 at "CNS Oncology"
DOI: 10.2217/cns-2022-0017
Abstract: Glioblastoma (GBM) is the most common malignant brain tumor. Less than 1% of patients survive longer than 10 years. A 77-year-old woman was diagnosed with MGMT-methylated GBM in 2009. The patient received cilengitide as part… read more here.
Keywords: survival older; long term; glioblastoma; patient ... See more keywords